Projects per year
Personal profile
Education
-
2013-2019 Ph.D, School of Pharmacy, Taipei Medical University, Taipei, Taiwan
-
2004-2006 M.S. in Clinical Pharmacy, National Cheng Kung University, Tainan, Taiwan
-
2000-2004 B.S. in Pharmacy, National Taiwan University, Taipei, Taiwan
Experience
- 2023- Assistant professor, School of Pharmacy, Taipei, Medical University, Taipei, Taiwan
- 2020-2023 Adjunct assistant professor, School of Pharmacy, Taipei, Medical University, Taipei, Taiwan
- 2019 Oncology training in National Cancer Centre Singapore
- 2017- Oncology pharmacist, Wanfang Hospital
- 2016- Board Certified Oncology Pharmacist, USA
- 2015 Oncology training in University of Illinois at Chicago, USA
- 2013-2020 Adjunct instructor, School of Pharmacy, Taipei, Medical University, Taipei, Taiwan
- 2008- Pharmacist, Department of Pharmacy, Wanfang Hospital
Research Interests
-
Clinical pharmacy
-
Cancer pharmacotherapy
-
Pharmacogenomic
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
免疫查核點抑制劑用於癌症治療之療效因子探討
Kuo, C.-N. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Impacts of the Response to Immune Checkpoint Inhibitors in Cancer Therapy: from Clinical Use to Gene Analysis
Kuo, C.-N. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
新聘教師研究補助
Kuo, C.-N. (PI)
1/15/24 → 1/14/25
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
-
運用生物資料庫研究方式探討胰臟癌治療標的及藥物探勘
Kuo, C.-N. (PI)
8/1/20 → 12/31/21
Project: A - Government Institution › b - National Science and Technology Council
-
Cost-effectiveness analysis of pembrolizumab with chemotherapy for metastatic nonsquamous non-small cell lung cancer in Taiwan
Lee, W.-L., Chou, W.-H., Chang, W.-P., Chang, T.-W., Kuo, C.-N. & Chang, W.-C., Dec 15 2024, In: Journal of Food and Drug Analysis. 32, 4, p. 568-576 9 p., 14.Research output: Contribution to journal › Article › peer-review
-
Effectiveness of pharmacist-managed oncology ambulatory care for patients with non-small cell lung cancer in Taiwan
Liu, D. C., Hung, C. L., Chen, Y. W., Kuo, L. N., Hsin, Y. C. & Kuo, C. N., 2024, In: Journal of Food and Drug Analysis. 32, 4, p. 558-567 10 p.Research output: Contribution to journal › Article › peer-review
-
Understanding the medication experience of patients with advanced non-small cell lung cancer taking epidermal growth factor receptor-tyrosine kinase inhibitors: A phenomenological study
Wen, M. J., Hsu, H. L., Chang, C. L., Wang, J. H., Kuo, C. N., Hsin, Y. C. & Chang, E. H., May 2023, In: PLoS ONE. 18, 5 MAY, e0286333.Research output: Contribution to journal › Article › peer-review
Open Access -
Effectiveness and Safety of Lower Dose of Rivaroxaban for Cancer-Related Venous Thromboembolism: A Retrospective Cohort Study
Chang, C. L., Lin, Y. J., Pan, C. C. & Kuo, C. N., Dec 2022, In: Annals of Pharmacotherapy. 56, 12, p. 1308-1314 7 p.Research output: Contribution to journal › Article › peer-review
-
Integrated genomic analysis to identify druggable targets for pancreatic cancer
Mugiyanto, E., Adikusuma, W., Irham, L. M., Huang, W. C., Chang, W. C. & Kuo, C. N., Dec 1 2022, In: Frontiers in Oncology. 12, p. 989077 989077.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)